A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials Article

Open Access International Collaboration

cited authors

  • Li, Lee X.; Socinski, Mark A.; Kichenadasse, Ganessan; Karapetis, Christos S.; Shahnam, Adel; Mckinnon, Ross A.; Rowland, Andrew; Hopkins, Ashley M.; Sorich, Michael J.

authors

Publication Date

  • March 25, 2024

webpage

published in

category

keywords

  • Body mass index
  • Chemoimmunotherapy
  • Immune checkpoint inhibitor
  • Non-small-cell lung cancer

volume

  • 24

issue

  • 1